鱼油辅助认知行为个案管理治疗青少年抑郁:随机双盲安慰剂对照多中心试验
这项随机双盲安慰剂对照多中心试验纳入15至25岁重性抑郁障碍患者233例,在认知行为个案管理基础上加用鱼油(二十碳五烯酸840毫克与二十二碳六烯酸560毫克)或安慰剂。结论不支持鱼油用于青少年重性抑郁障碍的治疗。
要点
- 鱼油辅助治疗12周未显著改善青少年重性抑郁障碍症状。
- 红细胞n-3多不饱和脂肪酸水平与抑郁严重程度无关联。
- 鱼油组与安慰剂组不良事件发生率及严重程度相似。
核心结论
- 在认知行为个案管理基础上加用鱼油,对15至25岁重性抑郁障碍患者的抑郁症状改善无优于安慰剂的效果。
研究设计与样本
- 随机双盲平行臂安慰剂对照多中心临床试验,纳入15至25岁重性抑郁障碍患者233例,随机分为鱼油组115例和安慰剂组118例。
主要发现
- 红细胞n-3多不饱和脂肪酸水平在干预前后均与抑郁严重程度无关。
- 两组不良事件的发生率和严重程度相似。
临床怎么用
- 不推荐将鱼油作为青少年重性抑郁障碍的常规辅助治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Clinical trials suggest that long-chain omega-3 polyunsaturated fatty acids (n-3 PUFAs) (fish oil) may reduce depressive symptoms in adults with major depressive disorder. Therefore, n-3 PUFAs may be a potential treatment for depression in youth. METHODS: Participants were 15- to-25 year-old individuals with major depressive disorder who sought care in one of three government-funded mental health services for young people in metropolitan Melbourne, Perth, or Sydney, Australia. Participants were randomly assigned in a double-blind, parallel-arm design to receive either fish oil (840 mg of eicosapentaenoic acid and 560 mg of docosahexaenoic acid) or placebo capsules as adjunct to cognitive behavioral case management. All participants were offered 50-minute cognitive behavioral case management sessions every 2 weeks delivered by qualified therapists (treatment as usual) at the study sites during the intervention period. The primary outcome was change in the interviewer-rated Quick Inventory of Depressive Symptomatology, Adolescent Version, score at 12 weeks. Erythrocyte n-3 PUFA levels were assessed pre-post intervention. RESULTS: A total of 233 young people were randomized to the treatment arms: 115 participants to the n-3 PUFA group and 118 to the placebo group. Mean change from baseline in the Quick Inventory of Depressive Symptomatology score was -5.8 in the n-3 PUFA group and -5.6 in the placebo group (mean difference, 0.2; 95% CI, -1.1 to 1.5; p = .75). Erythrocyte PUFA levels were not associated with depression severity at any time point. The incidence and severity of adverse events were similar in the two groups. CONCLUSIONS: This placebo-controlled trial and biomarker analysis found no evidence to support the use of fish oil for treatment in young people with major depressive disorder.
引用
- Amminger GP, Rice S, Davey CG, et al. The Addition of Fish Oil to Cognitive Behavioral Case Management for Youth Depression: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial. Biol Psychiatry. 2023. PMID: 37355004. doi:10.1016/j.biopsych.2023.06.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。